Personalised Medicine

A blood clot in the brain that blocks the supply of oxygen can cause an acute stroke. In this case, every minute counts. A team from Empa, the University Hospital in Geneva and the Hirslanden Clinic is currently developing a diagnostic procedure that can be used to start a tailored therapy in a timely manner, as they write in the current issue of the scientific journal Scientific Reports.

EPFL scientists discuss the possibility of offering personalized treatment for chronic lymphocytic leukemia by regulating the expression of a gene known for its “anti-tumorous” properties.

Robotic wheelchairs may soon be able to move through crowds smoothly and safely. As part of CrowdBot, an EU-funded project, EPFL researchers are exploring the technical, ethical and safety issues related to this kind of technology. The aim of the project is to eventually help the disabled get around more easily.

Human biology is the research focus of a number of EPFL labs, where scientists conduct clinical trials with volunteers to design therapeutic interventions and to learn more about how the body functions. Here, we take a closer look at the work of Prof. Friedhelm Hummel, who is developing therapies for stroke survivors.

Personalized medicine is set to revolutionize healthcare, yet large-scale research studies towards better diagnoses and targeted therapies are currently hampered by data privacy and security concerns. New global collaborative research has developed a solution to these challenges, described in Nature Communications.

An international team of scientists led by EPFL has developed a system that combines information from the brain’s connectome – the “wiring” between neurons – and machine learning to assess and predict the outcome of stroke victims.